Tag: Cancer: Bladder
High BMI in Childhood May Up Risk for Bladder Cancer as Adult
Height inversely linked to bladder cancer, while excess BMI gain in childhood linked to increased risk
Addition of Atezolizumab May Aid in Metastatic Urothelial Cancer
Phase 3 trial shows prolonged progression-free survival for atezolizumab plus platinum-based chemo
FDA Labeling Restriction Quickly Reflected in Oncology Practice
FDA label change linked to decrease in immunotherapy use, increases in chemotherapy use, PD-L1 testing
Quitting Smoking Lowers Risk for Bladder Cancer Postmenopause
Significant drop seen in first 10 years of cessation, continues to decrease as cessation time increases
American Urological Association, May 3-6
The American Urological Association 2019 Annual Meeting The annual meeting of the American Urological Association was held from May 3 to 6 in...
FDA Approves Personalized Tx for Metastatic Bladder Cancer
Balversa indicated for treatment of bladder cancer with FGFR3 or FGFR2 genetic alteration
Younger Age at Menopause Tied to Higher Risk for Bladder Cancer
Women with menopause onset by age 45 at higher risk than those with onset at age 50 or older
Smoking Associated With Worse Bladder Cancer Outcomes
Smokers had poorer response to cisplatin-based neoadjuvant chemotherapy, higher recurrence risk
Noninvasive Diagnostic Imaging Accurately IDs Bladder Cancer
Method evaluating cells collected from urine shows 94 percent diagnostic accuracy
Treatment Tied to Survival Benefit in Complex Bladder Cancer
Medically complex patients with superficial disease have reduced deaths with treatment vs. observation
